ABSTRACT
INTRODUCTION
Circadian rhythms are oscillations that recur daily and are intrinsic to a biological system because they continue in the absence of external inputs. To sustain such 24-hour rhythms an autonomous clock mechanism is working in every body cell. 1 Since these individually ticking cellular clocks do not have precisely the same period length, they need to be synchronized to each other for the generation of a coherent systemic circadian rhythm. This rhythm is useful for the organism to prepare itself for daily recurring events such as feeding and sleeping. By the same token, it allows an organism to temporally separate anabolic and catabolic processes and improve performance. Hence, coordination of cellular clocks is key to systemic function.
Furthermore, keeping the circadian system in resonance with the environment (e.g. day-night cycle) optimizes biological systems in order to allow them to maximally profit from food availability and geophysical properties such as light.
The mammalian circadian oscillator is constituted of an auto-regulatory transcriptional-translational feedback loop. 2 Two transcriptional activators BMAL1 and CLOCK (or NPAS2 in the brain) bind to E-box elements present on the promoters of other clock genes (or clock controlled genes) thereby supporting activation of their transcription.
Two classes of transcriptional repressors that are activated this way act back on the transcriptional activators either directly (REV-ERBα) by repressing the Bmal1 promoter, or indirectly via inhibition of the activity of the BMAL1/CLOCK complex (PERIOD and CRYPTOCHROME proteins). Various proteins including kinases, phosphatases and ubiquinating enzymes modulate the half-life and/or efficiency of nuclear transport of clock components, which ultimately leads to a roughly 24-hour rhythm of transcriptional activation of clock genes in the cell nucleus. It is evident that such a mechanism needs coordination between the activator and repressor components. Such coordination may be mediated by PERIOD2 (PER2), which can interact on one hand with the BMAL1/CLOCK complex influencing its activity 3, 4 and on the other hand with nuclear receptors modulating Bmal1 gene expression such as REV-ERBα and PPARα. 5 Furthermore, coordination between the clock mechanism and BMAL1/CLOCK mediated and/or nuclear receptor mediated transcription of genes is of great importance for generation of coherent systemic rhythms of metabolic gene expression. This coordination may again be mediated by PER2 in its capacity to interact with both nuclear receptors and clock proteins. 5
Interaction potential of the PER2 protein
The PER proteins bear several protein-protein interaction domains that allow them to interact with a multitude of proteins such as BMAL1/CLOCK and CRY1. 3, 6 These interactions may form the basis for the molecular oscillator. Previously, we found two additional classes of interaction motifs in the PER proteins: the CoRNR and LXXLL motifs, 7 which are characteristic for interactions of nuclear receptors with their co-regulators. 8, 9 While the putative CoRNR boxes are well conserved between the different isoforms of PER proteins, they differ in their potential LXXLL motifs. Based on these observations, we examined whether the PER2 protein could physically interact with nuclear receptors. 5 Nuclear receptors are potent transcriptional regulators and control the expression of multiple genes involved in various processes such as development, reproduction and metabolism. 10, 11 In an in vitro assay, we supplemented mouse NIH 3T3 fibroblasts with expression vectors for V5-tagged PER2 and for HA-tagged nuclear receptors to monitor physical interactions by coimmunoprecipitation. Our selection of nuclear receptors included receptors that are either known to influence the circadian oscillator or are expressed in a similar phase than the PER proteins in liver. 10 We observed in vitro physical interactions of PER2 with several nuclear receptors such as REV-ERBα, PPARα, NURR1, HNF4α and TRα. These interactions depended on the presence of LXXLL-like sequences in PER2. Taken together, PER2 has the capacity to physically interact with a selection of nuclear receptors, extending the regulatory potential of PER2.
Target gene regulation by PER2
Similarly to our in vitro results, PER2 was found to form complexes with the nuclear Therefore, PER2 may modulate the repressive potential of REV-ERBα. Interestingly, the peaks of Per2 and Rev-Erbα mRNA accumulation were separated by roughly 8 hours in synchronized cells (Fig. 1B) . This was also reflected by a separation of the corresponding protein peaks by about the same interval (Fig. 1C) . Consequently, there is only a small temporal overlap between both proteins. This time window corresponds to the moment when both proteins are present at the Bmal1 promoter region. As a speculation, binding to the regulatory region is driven by post-translational modifications in either of the two proteins.
The interaction of both proteins may shape the accumulation of Bmal1, because PER2
modulates REV-ERBα repressive activity.
In NIH 3T3 fibroblasts, binding of RORα seems to be independent of PER2 (Fig. 1A) .
The alternate binding of RORα and REV-ERBα to the same regulatory element of the Bmal1 gene is in agreement with previous studies. 14, 15 According to this regulatory model, both nuclear receptors may compete for the same DNA binding element. It can be speculated that PER2 might influence this competition and therefore modulates the balance between activation and repression of Bmal1. However, this remains to be elucidated. REV-ERBα recruits the corepressor N-CoR1 for its repressive function on the Bmal1 promoter. Taken together, our data suggest that PER2 acts as co-regulator in the stabilizing loop of the circadian oscillator in NIH 3T3 fibroblasts. Thus, the function of PER2 in this pathway may occur in essentially all tissue clocks.
Distinct influences of nuclear receptors on the circadian oscillator
Previously, the influence of PPARα and REV-ERBα on two different circadian reporter genes was analyzed. 5 PPARα together with its heterodimerisation partner RXRα did not affect expression of either of the two reporter genes. By contrast, co-transfection of REV-ERBα repressed activity of the Rev-Erbα and Bmal1 luciferase reporter vectors in NIH 3T3 fibroblasts ( Fig. 2A and Schmutz et al. 5 ). Here we extend the analysis using other nuclear receptors that either can be immunoprecipitated with PER2 in vitro (NURR1, HNF4α, TRα) or can not be immunoprecipitated with PER2 (RORα, ERα, RXRα). Based on their action on the reporter constructs Rev-Erbα luc and Bmal1 luc in NIH 3T3 cells, we could define three groups of nuclear receptors (Fig. 2) . Group I represented by REV-ERBα and NURR1
repressed the activity of either the Rev-Erbα or Bmal1 luciferase reporter gene ( Fig. 2A) , group II represented by RORα and ERα activated at least one reporter gene (Fig. 2B) , and group III represented by HNF4α, RXRα and TRα did not have a measurable impact on their activity (Fig. 2C) . Hence, not only the standard nuclear receptors involved in the stabilizing loop (RORα, REV-ERBα, and PPARα) are capable to feed back on clock gene expression.
Other nuclear receptors such as NURR1 and ERα may directly or indirectly fulfill a similar function.
To monitor the impact of PER2 on these different groups of nuclear receptors, we performed co-transfection experiments (Fig. 3) . Co-transfection with increasing amounts of PER2 elevated specifically the level of Bmal1-driven luciferase activity as observed previously. 5 For co-transfection experiments with the additional nuclear receptors, we kept the amount of Per2-V5 expression vector constant. The nuclear receptor NURR1 alone decreased Bmal1 luc activity in a dose-dependent fashion ( Fig. 2A, 3A) . Co-transfection with PER2 modulated this effect. NURR1-mediated repression of Bmal1 luc activity was attenuated in the trough of cycling (Fig. 3A) . This resembled a similar experiment performed previously with PER2 and REV-ERBα (suppl. Fig. 7 in Schmutz et al. 5 ). Hence, NURR1 and REV-ERBα both act as transcriptional repressors of Bmal1 reporter activity and their repressive potential is modulated by PER2.
The transcriptional activator PPARα alone does not change Bmal1 reporter activity but shows synergism together with PER2 in the presence of RXRα. 5 By contrast, cotransfection of RORα did not affect the action of PER2 on Bmal1 (Fig. 3B ). This could indicate that action of RORα on this gene is independent of PER2 as it was already suggested by the ChIP results (Fig. 1A) In this study, we provide evidence that the nuclear receptor NURR1 is modulated in its activity by PER2 in NIH3T3 cells. This nuclear receptor plays an essential role in the generation and maintenance of dopaminergic neurons in the brain. 21 It is involved in the regulation of genes coding for aromatic amino acid decarboxylases, tyrosine hydroxylase (TH), and the dopamine transporter 22 leading to the notion that it plays an important role in dopaminergic nerve function and diseases associated with the dopaminergic system. In agreement with this notion it appears that NURR1 is involved in depression-like behavior in mice 23, 24 and its expression is reduced in the brain of schizophrenic and bipolar patients. 25 Interestingly, mice with a mutation in the clock gene Per2 show alterations in mood related behaviors associated with elevated dopamine levels in the mesolimbic dopaminergic system. 26 In these animals, TH expression in the nucleus accumbens is not diurnal in contrast to wild type controls. 27 This suggests that NURR1-mediated transcription of TH is modulated by PER2, which no longer occurs in Per2 mutant mice. However, regulation of the TH promoter by NURR1 and PER2 needs to be investigated in the future to test this hypothesis. 
CONCLUSIONS

MATERIALS and METHODS
Chromatin Immunoprecipitation (ChIP) from NIH 3T3 cells
NIH 3T3 cells were grown to confluency in DMEM High Glucose (Sigma) supplemented with 10 % fetal calf serum and 100 U/ml penicillin/streptomycin (Amimed) on 15 cm plates.
After synchronization with 100 nM dexamethasone, 28 
RNA quantification from NIH 3T3 cells
Total RNA was extracted from cells using RNA-Bee (AMS Biotechnology) according to the manufacturer. RNA was further purified by phenol:chloroform:isoamylalcohol extraction and ethanol precipitation. ssDNA complementary to the RNA was synthesized with Superscript II (Life Technology Corporation) according to the manufacturer starting from hybridized random hexamer primers. mRNA levels were quantified by Taqman real-time PCR. PCR probes have been described. 5 After normalization to Gapdh mRNA accumulation, relative mRNA levels were assessed by defining the highest value of each experiment as 1.
Cellular fractionation and Western blot analysis
For cellular fractionation, cells were broken by swelling the cells in 100 mM Tris-HCl pH 8.8/ 10 mM DTT and subsequent hypotonic lysis (10 mM EDTA, 1 mM EGTA, 10 mM Hepes pH 6.8, 0.2 % Triton-X 100, 0.5 mM DTT, protease inhibitor cocktail, 0.2 mM NaV, 5 mM NaF). After centrifugation for 5 minutes at 2,500 g and 4°C, the supernatant was stored as cytosolic fraction. Nuclear extracts were prepared from purified nuclei according to the NUN procedure 29 . Briefly, nuclei were re-suspended in 1x NDB (100 mM KCl, 0.2 mM EDTA, 20 % glycerol, 20 mM Hepes pH 7.6, 2 mM DTT) and an equal volume of 2x NUN (600 mM NaCl, 2 M Urea, 2 % NP-40, 50 mM Hepes pH 7.6) was added. After mixing, the samples were incubated on ice for 30 min and centrifuged for 30 min at 16,000 g and 4°C.
The supernatant was stored as nuclear extract. Western blot analysis was performed according to Schmutz et al. 5
Real-time bioluminescence monitoring
Expression vectors and luciferase reporter vectors were as described in Schmutz et al. 
